Memantin Genericon (Memantine Hydrochloride)

Memantine works by binding to the NMDA‑type glutamate receptor as an uncompetitive antagonist. This blocks excessive calcium entry that occurs during pathological glutamate stimulation, reducing excitotoxic neuronal damage while allowing normal synaptic activity essential for learning and memory.

The dosage of Memantin Genericon is determined by the prescribing clinician based on the individual’s clinical status, renal function, and tolerability. Typical regimens start with a low dose that may be titrated upward, but exact dosing should follow the prescriber’s instructions.

Safety data for memantine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

The primary alternative for Alzheimer’s disease is the acetylcholinesterase inhibitor class (e.g., donepezil). While acetylcholinesterase inhibitors enhance cholinergic transmission, memantine modulates glutamatergic activity. Both classes may be used alone or together, offering complementary mechanisms that can improve different aspects of cognition and behavior.

Store the product at room temperature, below 25 °C, in the original packaging. Keep it away from moisture, direct sunlight, and excessive heat. Do not refrigerate or freeze the tablets, and ensure the container is tightly closed to maintain product stability.

Memantin Genericon is taken orally, with or without food, as directed by the prescriber. The tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically advised.

Serious adverse events, although uncommon, include seizures, cardiac arrhythmias, and severe skin reactions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience unexplained convulsions, irregular heartbeats, or widespread rash with blistering.

Memantin Genericon should be avoided in individuals with known hypersensitivity to memantine or any excipients, in patients with severe renal impairment without dose adjustment, and in those concurrently receiving other NMDA‑receptor antagonists. Consultation with a healthcare provider is essential before initiating therapy.